763 related articles for article (PubMed ID: 21488901)
1. Oral tolerance.
Weiner HL; da Cunha AP; Quintana F; Wu H
Immunol Rev; 2011 May; 241(1):241-59. PubMed ID: 21488901
[TBL] [Abstract][Full Text] [Related]
2. Oral tolerance: therapeutic implications for autoimmune diseases.
Faria AM; Weiner HL
Clin Dev Immunol; 2006; 13(2-4):143-57. PubMed ID: 17162357
[TBL] [Abstract][Full Text] [Related]
3. Cellular Components and Mechanisms of Oral Tolerance Induction.
Rezende RM; Weiner HL
Crit Rev Immunol; 2018; 38(3):207-231. PubMed ID: 30004858
[TBL] [Abstract][Full Text] [Related]
4. Oral tolerance: immune mechanisms and the generation of Th3-type TGF-beta-secreting regulatory cells.
Weiner HL
Microbes Infect; 2001 Sep; 3(11):947-54. PubMed ID: 11564443
[TBL] [Abstract][Full Text] [Related]
5. Oral tolerance: elucidation of mechanisms and application to treatment of autoimmune diseases.
Fowler E; Weiner HL
Biopolymers; 1997; 43(4):323-35. PubMed ID: 9316395
[TBL] [Abstract][Full Text] [Related]
6. Intranasal immunization with heat shock protein 60 induces CD4(+) CD25(+) GARP(+) and type 1 regulatory T cells and inhibits early atherosclerosis.
Zhong Y; Tang H; Wang X; Zeng Q; Liu Y; Zhao XI; Yu K; Shi H; Zhu R; Mao X
Clin Exp Immunol; 2016 Mar; 183(3):452-68. PubMed ID: 26452441
[TBL] [Abstract][Full Text] [Related]
7. CD4+CD25+ T regulatory cells and TGF-beta in mucosal immune system: the good and the bad.
Chen W; Perruche S; Li J
Curr Med Chem; 2007; 14(21):2245-9. PubMed ID: 17896973
[TBL] [Abstract][Full Text] [Related]
8. Oral tolerance.
Faria AM; Weiner HL
Immunol Rev; 2005 Aug; 206():232-59. PubMed ID: 16048553
[TBL] [Abstract][Full Text] [Related]
9. Regulatory T-cell abnormalities and the global epidemic of immuno-inflammatory disease.
de St Groth BF
Immunol Cell Biol; 2012 Mar; 90(3):256-9. PubMed ID: 22310378
[TBL] [Abstract][Full Text] [Related]
10. Oral CD3-specific antibody suppresses autoimmune encephalomyelitis by inducing CD4+ CD25- LAP+ T cells.
Ochi H; Abraham M; Ishikawa H; Frenkel D; Yang K; Basso AS; Wu H; Chen ML; Gandhi R; Miller A; Maron R; Weiner HL
Nat Med; 2006 Jun; 12(6):627-35. PubMed ID: 16715091
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic anti-CD3 monoclonal antibodies: from bench to bedside.
Kuhn C; Weiner HL
Immunotherapy; 2016 Jul; 8(8):889-906. PubMed ID: 27161438
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of Oral Tolerance.
Tordesillas L; Berin MC
Clin Rev Allergy Immunol; 2018 Oct; 55(2):107-117. PubMed ID: 29488131
[TBL] [Abstract][Full Text] [Related]
13. Treg Enhancing Therapies to Treat Autoimmune Diseases.
Eggenhuizen PJ; Ng BH; Ooi JD
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32977677
[TBL] [Abstract][Full Text] [Related]
14. Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens.
Weiner HL; Friedman A; Miller A; Khoury SJ; al-Sabbagh A; Santos L; Sayegh M; Nussenblatt RB; Trentham DE; Hafler DA
Annu Rev Immunol; 1994; 12():809-37. PubMed ID: 8011298
[TBL] [Abstract][Full Text] [Related]
15. The role of regulatory T Cells in autoimmune orchitis.
Jacobo P
Andrologia; 2018 Dec; 50(11):e13092. PubMed ID: 30569653
[TBL] [Abstract][Full Text] [Related]
16. Oral tolerance in the control of experimental models of autoimmune disease.
Staines NA; Harper N
Z Rheumatol; 1995; 54(3):145-54. PubMed ID: 7660685
[TBL] [Abstract][Full Text] [Related]
17. Type II collagen oral tolerance; mechanism and role in collagen-induced arthritis and rheumatoid arthritis.
Park KS; Park MJ; Cho ML; Kwok SK; Ju JH; Ko HJ; Park SH; Kim HY
Mod Rheumatol; 2009; 19(6):581-9. PubMed ID: 19697097
[TBL] [Abstract][Full Text] [Related]
18. Effects of immunomodulators on the response induced by vaccines against autoimmune diseases.
Marciani DJ
Autoimmunity; 2017 Nov; 50(7):393-402. PubMed ID: 28906131
[TBL] [Abstract][Full Text] [Related]
19. Treatment of autoimmune disease by oral tolerance to autoantigens.
Whitacre CC; Gienapp IE; Meyer A; Cox KL; Javed N
Clin Immunol Immunopathol; 1996 Sep; 80(3 Pt 2):S31-9. PubMed ID: 8811061
[TBL] [Abstract][Full Text] [Related]
20. Mucosally induced immunological tolerance, regulatory T cells and the adjuvant effect by cholera toxin B subunit.
Sun JB; Czerkinsky C; Holmgren J
Scand J Immunol; 2010 Jan; 71(1):1-11. PubMed ID: 20017804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
